Document Detail


Switching from human insulin to biphasic insulin aspart 30 treatment gets more patients with type 2 diabetes to reach target glycosylated hemoglobin < 7%: the results from the China cohort of the PRESENT study.
MedLine Citation:
PMID:  20529546     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The clinical importance of glycaemic control in patients with diabetes has been well established. This study aimed to explore twice-daily biphasic insulin aspart 30 (BIAsp 30) for insulin initiation in patients with type 2 diabetes mellitus (T2DM) who had poor glycaemic control with human insulins (HIs). We use data from a Chinese cohort of the PRESENT study. METHODS: In the 3-month study, Chinese subjects with T2DM started insulin therapy with BIAsp 30 in routine care. Glycaemic control was measured by glycosylated hemoglobin (HbA(1C)), fasting plasma glucose (FPG) and posting plasma glucose (PPG). The safety assessment included hypoglycaemia and other adverse events. RESULTS: A total of 1989 subjects previously treated with His were switched to BIAsp 30 for 3-month treatment. Mean HbA(1C), FPG and PPG were significantly improved after the therapy. The overall rate of hypoglycaemia decreased at the end of the trial except for the patients previously treated with long-acting insulin. Most of the events were minor and diurnal hypoglycaemia. Only one serious adverse drug reaction (SADR), a local hypersensitivity, was reported. The majority of the patients (> or = 96.7%) and physicians (> or = 84.7%) were either satisfied or very satisfied with the treatment using BIAsp 30 compared with previous HI therapy. CONCLUSION: The BIAsp 30 treatment improved both glycaemic control and patients' satisfaction without increasing hypoglycaemia in T2DM subjects inadequately controlled by His.
Authors:
Yan Gao; Xiao-hui Guo
Related Documents :
15703976 - Severe hypoglycaemia, metabolic control and diabetes management in children with type 1...
231776 - An insulinoma presenting with reactive hypoglycaemia.
19183316 - Prevalence and reasons for insulin refusal in bangladeshi patients with poorly controll...
9400916 - Symptomatic and physiological responses to hypoglycaemia induced by human soluble insul...
6341126 - Abnormalities of gip in spontaneous syndromes of obesity and diabetes in mice.
19534826 - Parental diabetes status reveals association of mitochondrial dna haplogroup j1 with ty...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Chinese medical journal     Volume:  123     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-06-09     Completed Date:  2010-09-14     Revised Date:  2010-11-15    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  1107-111     Citation Subset:  IM    
Affiliation:
Department of Endocrinology, Peiking University First Hospital, Beijing 100034, China. gaoyanpku@yahoo.cn
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Diabetes Mellitus, Type 2 / drug therapy*,  metabolism*
Female
Hemoglobin A, Glycosylated / drug effects*
Humans
Insulin / administration & dosage,  adverse effects,  analogs & derivatives*,  pharmacology,  therapeutic use*
Male
Middle Aged
Prospective Studies
Treatment Outcome
Chemical
Reg. No./Substance:
0/Hemoglobin A, Glycosylated; 0/insulin aspart; 11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Re: JSLS. 2009;13:19-21 Laparoscopic supracervical hysterectomy for benign gynecological conditions.
Next Document:  Therapeutic effects of potassium sodium hydrogen citrate on melamine-induced urinary calculi in Chin...